Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
7
×
boston blog main
boston top stories
7
×
life sciences
national blog main
startups
7
×
clinical trials
deals
investing
national top stories
new york blog main
medical device
new york top stories
fda
perceptive advisors
third rock ventures
venture capital
20/20 healthcare partners
480 biomedical
abbott laboratories
adel malek
adeno-associated virus
allosteric
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
antisense oligonucleotide
arsenal medical
atlas venture
aton partners
atopic dermatitis
autoimmune disorders
azacitidine
benzodiazepines
beta-thalassemia
biogen
blackstone group
blackstone life sciences
bob langer
What
new
drugs
medicines
therapeutics
address
ago
aims
biotech
called
developing
device
disease
neuro
raised
research
years
absorb
adding
adds
aiming
allosteric
approach
associated
backed
balance
based
body
brain
build
builds
cause
ceo
cerevasc
clinic
companies
company
debut
debuts
decibel
develop
Language
unset
7
×
Current search:
unset
×
startups
×
" boston top stories "
×
boston
×
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further